These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36417678)

  • 21. MMP9 gene polymorphism is not associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population.
    Zeng R; Zhang X; Wu K; Su Y; Wen F
    Ophthalmic Genet; 2014 Dec; 35(4):235-40. PubMed ID: 25162123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine Profiling in Patients With Exudative Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Agrawal R; Balne PK; Wei X; Bijin VA; Lee B; Ghosh A; Narayanan R; Agrawal M; Connolly J
    Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):376-382. PubMed ID: 30682207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Amyloid A 4 as a Common Marker of Persistent Inflammation in Patients with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Liu Q; Sun S; Yang Z; Shao Y; Li X
    J Inflamm Res; 2023; 16():3783-3797. PubMed ID: 37663754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population.
    Zhang X; Li M; Wen F; Zuo C; Chen H; Wu K; Zeng R
    Exp Eye Res; 2013 Mar; 108():16-22. PubMed ID: 23274582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Cholesterol Efflux Capacity in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Yanagi Y; Yu RMC; Ahamed W; Yu M; Teo KYC; Tan ACS; Cheng CY; Wong TY; Apte RS; Cheung CMG
    Ophthalmol Sci; 2022 Jun; 2(2):100142. PubMed ID: 36278032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Systemic and Serum Risk Factors in Patients with Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Tao T; Xu H; Ma X; Cheng Y; Shi X; Sun Y; Zhao M; Huang L; Li X
    Ophthalmol Ther; 2023 Apr; 12(2):1033-1044. PubMed ID: 36680656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jin KW; Kim JH; Park JY; Park SJ; Park KH; Lee JY; Woo SJ
    Sci Rep; 2021 Jul; 11(1):14623. PubMed ID: 34272419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population.
    Mori K; Horie-Inoue K; Gehlbach PL; Takita H; Kabasawa S; Kawasaki I; Ohkubo T; Kurihara S; Iizuka H; Miyashita Y; Katayama S; Awata T; Yoneya S; Inoue S
    Ophthalmology; 2010 May; 117(5):928-38. PubMed ID: 20132989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians.
    Yadav S; Parry DG; Beare NAV; Pearce IA
    Br J Ophthalmol; 2017 Oct; 101(10):1377-1380. PubMed ID: 28270486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in China.
    Meng Q; Huang L; Sun Y; Bai Y; Wang B; Yu W; Zhao M; Li X
    PLoS One; 2015; 10(12):e0143924. PubMed ID: 26624898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvements of Retinal Sensitivity after Intravitreal Injection of Aflibercept in Eyes with Neovascular Age-Related Macular Degeneration with or without Polypoidal Choroidal Vasculopathy.
    Nizawa T; Kitahashi M; Baba T; Iwase T; Kubota-Taniai M; Hattori Y; Shiko Y; Kawasaki Y; Iwase T; Sato T; Ogawa S; Sugawara T; Yamamoto S
    Ophthalmologica; 2021; 244(4):347-360. PubMed ID: 34015785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of plasma malondialdehyde with ARMS2 genetic variants and phenotypes in polypoidal choroidal vasculopathy and age-related macular degeneration.
    Park DH; Shin JP; Kim IT
    Retina; 2014 Jun; 34(6):1167-76. PubMed ID: 24240564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting: A Multicenter Cohort Study in Japan.
    Yoneda K; Takeuchi M; Yasukawa T; Terasaki H; Yamamoto Y; Jujo T; Wakuta M; Matsubara H; Mitamura Y; Kato A; Kondo M; Kimura K; Takagi H; Gomi F; Sakamoto T;
    Ophthalmol Retina; 2023 Oct; 7(10):869-878. PubMed ID: 37295608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Subhi Y; Krogh Nielsen M; Molbech CR; Krüger Falk M; Singh A; Hviid TVF; Nissen MH; Sørensen TL
    JAMA Ophthalmol; 2019 May; 137(5):515-522. PubMed ID: 30844038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept.
    Sato T; Enoki T; Karasawa Y; Someya H; Taguchi M; Harimoto K; Takayama K; Kanda T; Ito M; Takeuchi M
    Front Immunol; 2021; 12():738521. PubMed ID: 34721402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
    Tong JP; Chan WM; Liu DT; Lai TY; Choy KW; Pang CP; Lam DS
    Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of
    Chen ZJ; Ma L; Brelen ME; Chen H; Tsujikawa M; Lai TY; Ho M; Sayanagi K; Hara C; Hashida N; Tam PO; Young AL; Nishida K; Tham CC; Pang CP; Chen LJ
    Br J Ophthalmol; 2021 Jul; 105(7):1035-1040. PubMed ID: 32152144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration.
    Kato Y; Oguchi Y; Omori T; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Ishida Y; Machida T; Sekine H; Sekiryu T
    Ophthalmol Sci; 2022 Jun; 2(2):100167. PubMed ID: 36249678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of ABCG1 With Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Chinese and Japanese.
    Ma L; Liu K; Tsujikawa M; Chen H; Brelen ME; Chan VC; Lai TY; Sayanagi K; Hara C; Hashida N; Tam PO; Young AL; Chen W; Nishida K; Pang CP; Chen LJ
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5758-5763. PubMed ID: 27787563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.